HEARTFLOW INC
HTFLNASDAQTrading Snapshot
- Day Range
- $49.56 – $50.76
- 52-Week Range
- $20.13 – $52.22
- Volume
- $5.20B
- Avg Volume
- $4.80B
- Shares Outstanding
- 86.2M
- Next Earnings
- Dec 6, 2026
Fundamentals Snapshot
- Annual Revenue
- $176M
- Last Q Revenue
- $64M
- P/E Ratio
- -35.2
- P/S Ratio
- 20.3x
- EPS (TTM)
- $-1.37
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +34.4%
Why Investors Own HTFL
- ✓High-growth profile — revenue up +47.4% YoY with expanding US Equity exposure.
- ✓Healthy economics — 73% gross margin and 6% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
HEARTFLOW INC
HTFL
StockOtter · stockotter.spaceAbout HEARTFLOW INC
HeartFlow, Inc. operates as a global medical technology firm, specializing in providing non-surgical solutions for the diagnosis and ongoing management of coronary artery disease. Its innovative HeartFlow Platform employs artificial intelligence and advanced computational fluid dynamics to generate a unique, three-dimensional digital replica of a patient's heart. This intricate model is created from a single coronary computed tomography angiography (CCTA), which is a specialized scan designed to produce highly detailed images of the heart's arterial network. The platform offers vital insights into aspects like blood flow, the extent of arterial narrowing (stenosis), and the volume and composition of any plaque present, thereby overcoming the limitations typically associated with traditional non-invasive imaging techniques. Founded in 2007, the company is headquartered in Mountain View, California.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Analyst Ratings
ⓘLatest News & Updates
Vikram Verghese Sells 7,579 Shares of Heartflow (NASDAQ:HTFL) Stock
Heartflow, Inc. (NASDAQ: HTFL - Get Free Report) CFO Vikram Verghese sold 7,579 shares of the firm's stock in a transaction on Thursday, September 17th. The stock was sold at an average price of $50.11, for a total value
Heartflow (NASDAQ:HTFL) Reaches New 52-Week High – Still a Buy?
Heartflow, Inc. (NASDAQ: HTFL - Get Free Report)'s share price reached a new 52-week high during trading on Friday. The company traded as high as $52.22 and last traded at $51.2010, with a volume of 1599729 shares. The s
12,278 Shares in Heartflow, Inc. $HTFL Bought by Amundi
Amundi bought a new stake in Heartflow, Inc. (NASDAQ: HTFL) during the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investo
John C.M. Farquhar Sells 35,010 Shares of Heartflow (NASDAQ:HTFL) Stock
Heartflow, Inc. (NASDAQ: HTFL - Get Free Report) CEO John Farquhar sold 35,010 shares of the stock in a transaction on Thursday, September 10th. The stock was sold at an average price of $46.42, for a total value of $1,6
HeartFlow's CEO Sells 38,900 Shares for $1.8 Million After the Stock Hit a 52-Week High
The transaction involved 38,900 shares valued at ~$1.8 million based on a weighted average price of $46.78 per share. The executive traded shares equal to 11% of the equity stake held before the filing.
Heartflow (NASDAQ:HTFL) versus American Well (NYSE:AMWL) Financial Analysis
American Well (NYSE: AMWL - Get Free Report) and Heartflow (NASDAQ: HTFL - Get Free Report) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their